About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

Business Address

Head Office

Ansec House 3 rd floor Tank Road, Yerwada, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 2315155523

[email protected]

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2026 PRDUA Research & Media Private Limited, All rights reserved

Privacy Policy
Terms and Conditions
FAQ
Report banner
Home
Industries
Machinery & Equipment
Machinery & Equipment

report thumbnailActive Exoskeleton

Active Exoskeleton Strategic Insights: Analysis 2025 and Forecasts 2033

Active Exoskeleton by Type (Lower Limbs Power Type, Waist Power Type, Upper Limbs Power Type), by Application (Medical Rehabilitation, Emergency Rescue, Outdoor, Other), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034

Jan 21 2026

Base Year: 2025

127 Pages

Main Logo

Active Exoskeleton Strategic Insights: Analysis 2025 and Forecasts 2033

Main Logo

Active Exoskeleton Strategic Insights: Analysis 2025 and Forecasts 2033


Related Reports


report thumbnailMedical Exoskeletons

Medical Exoskeletons 5 CAGR Growth Outlook 2025-2033

report thumbnailMedical Exoskeleton

Medical Exoskeleton 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

report thumbnailWearable Exoskeleton

Wearable Exoskeleton 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

report thumbnailExoskeleton Systems

Exoskeleton Systems Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

report thumbnailExoskeleton

Exoskeleton Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

+1 2315155523

[email protected]

  • Home
  • About Us
  • Industries
    • Chemicals & Materials
    • Automotive & Transportation
    • Machinery & Equipment
    • Agriculture
    • COVID-19 Analysis
    • Energy & Power
    • Consumer Goods
    • Packaging
    • Food & Beverages
    • Semiconductor & Electronics
    • Information & Technology
    • Healthcare
    • Aerospace & Defense
  • Services
  • Contact
Main Logo
  • Home
  • About Us
  • Industries
    • Chemicals & Materials
    • Automotive & Transportation
    • Machinery & Equipment
    • Agriculture
    • COVID-19 Analysis
    • Energy & Power
    • Consumer Goods
    • Packaging
    • Food & Beverages
    • Semiconductor & Electronics
    • Information & Technology
    • Healthcare
    • Aerospace & Defense
  • Services
  • Contact
[email protected]
Get Free Sample
Hover animation image
Pre Order Enquiry Request discount

Pricing

$6960.00
Corporate License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
$5220.00
Multi User License:
  • The report will be emailed to you in PDF format.
  • Allows 1-10 employees within your organisation to access the report.
$3480.00
Single User License:
  • Only one user can access this report at a time
  • Users are not allowed to take a print out of the report PDF
BUY NOW

Related Reports

Medical Exoskeletons 5 CAGR Growth Outlook 2025-2033

Medical Exoskeletons 5 CAGR Growth Outlook 2025-2033

Medical Exoskeleton 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Medical Exoskeleton 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Wearable Exoskeleton 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Wearable Exoskeleton 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Exoskeleton Systems Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

Exoskeleton Systems Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

Exoskeleton Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

Exoskeleton Analysis 2025 and Forecasts 2033: Unveiling Growth Opportunities

sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

Key Insights

The global active exoskeleton market is poised for significant expansion, propelled by escalating demand for advanced rehabilitation solutions, continuous breakthroughs in robotics and sensor technology, and a growing elderly demographic necessitating enhanced mobility assistance. The adoption of exoskeletons in industrial applications to boost worker productivity and safety in physically demanding roles further fuels market growth. While initial investment costs present a notable challenge, ongoing technological advancements are paving the way for more cost-effective and accessible systems. We project the market size to reach $850 million by 2025, with an estimated compound annual growth rate (CAGR) of 21.4% over the forecast period. This robust CAGR underscores the confluence of critical technological and demographic drivers propelling market advancement.

Active Exoskeleton Research Report - Market Overview and Key Insights

Active Exoskeleton Market Size (In Million)

3.0B
2.0B
1.0B
0
850.0 M
2025
1.032 B
2026
1.253 B
2027
1.521 B
2028
1.846 B
2029
2.241 B
2030
2.721 B
2031
Main Logo

Geographically, North America and Europe currently dominate market share, attributed to their well-developed healthcare infrastructures and higher adoption rates in industrial sectors. Conversely, the Asia-Pacific region is anticipated to experience the most rapid growth, driven by increasing investments in healthcare technology, rising disposable incomes, and an expanding elderly population. Key market restraints include high development and manufacturing costs, regulatory complexities for medical device approvals, and the necessity for skilled personnel. Nevertheless, sustained innovation, strategic collaborations, and increasing government support for assistive technologies are expected to overcome these obstacles and accelerate market growth throughout the next decade. The market is segmented by application (rehabilitation, industrial, military), type (upper body, lower body, full body), and technology (hydraulic, electric, pneumatic). Leading companies such as Ekso Bionics, ReWalk Robotics, and Hocoma are at the forefront of innovation, enhancing the functionality, affordability, and accessibility of active exoskeleton solutions.

Active Exoskeleton Market Size and Forecast (2024-2030)

Active Exoskeleton Company Market Share

Loading chart...
Main Logo

Active Exoskeleton Trends

The global active exoskeleton market is experiencing robust growth, projected to reach multi-billion dollar valuations by 2033. Driven by technological advancements, increasing geriatric populations, and rising demand for rehabilitation solutions, the market demonstrates significant potential across various sectors. The historical period (2019-2024) witnessed steady expansion, laying the groundwork for the substantial growth anticipated during the forecast period (2025-2033). By 2025 (estimated year), the market is expected to surpass several hundred million units, indicating a substantial increase from previous years. This growth isn't uniform across all applications. While the medical rehabilitation segment currently dominates, substantial opportunities are emerging in industrial settings, particularly in logistics and manufacturing, where exoskeletons can enhance worker productivity and reduce the risk of musculoskeletal injuries. Furthermore, the military and defense sectors are increasingly exploring the use of active exoskeletons to enhance soldier capabilities. This trend towards diversification reflects the versatility and adaptability of exoskeleton technology, driving innovation and expanding market applications. The increasing affordability and accessibility of exoskeletons, coupled with supportive government regulations and initiatives, are further accelerating market expansion. However, challenges related to high initial costs, technological limitations, and regulatory hurdles remain. Despite these obstacles, the long-term growth trajectory of the active exoskeleton market remains overwhelmingly positive, with a projected Compound Annual Growth Rate (CAGR) indicating strong and consistent expansion over the next decade. This growth signifies a significant shift towards a future where exoskeletons are increasingly integrated into daily life, revolutionizing healthcare, industrial practices, and beyond. Key market insights suggest a strong focus on developing lighter, more comfortable, and energy-efficient exoskeletons that cater to diverse user needs and application requirements.

Driving Forces: What's Propelling the Active Exoskeleton Market?

Several key factors fuel the remarkable growth trajectory of the active exoskeleton market. Firstly, the burgeoning aging global population creates a substantial demand for assistive devices, with exoskeletons offering enhanced mobility and independence for the elderly. Secondly, the rising prevalence of musculoskeletal disorders and neurological conditions necessitates effective rehabilitation solutions, driving adoption in healthcare settings. Exoskeletons provide targeted support and therapy, accelerating recovery and improving patient outcomes. Thirdly, the industrial sector is witnessing a surge in demand for exoskeletons due to their potential to enhance worker safety and productivity by reducing strain injuries and increasing efficiency in physically demanding tasks. The growing focus on workplace ergonomics and injury prevention is further propelling adoption. Furthermore, technological advancements, such as improved sensor technology, more powerful and efficient actuators, and advanced control systems, are continually enhancing the performance and capabilities of exoskeletons, making them more practical and appealing across diverse sectors. Finally, increasing government support through research funding, regulatory approvals, and initiatives aimed at promoting assistive technology adoption are creating a favorable environment for market expansion. These combined factors contribute to the sustained and accelerated growth of the active exoskeleton market, paving the way for widespread adoption in the years to come.

Challenges and Restraints in Active Exoskeleton Market

Despite the significant growth potential, the active exoskeleton market faces notable challenges. High initial costs and ongoing maintenance expenses often pose a significant barrier to widespread adoption, particularly for individual consumers and smaller businesses. Technological limitations, such as limited battery life, bulkiness, and lack of dexterity in some models, also restrict broader applications. Regulatory hurdles vary across different regions, creating complexities for manufacturers seeking global market access. Furthermore, concerns regarding safety and user comfort need continuous addressal to build trust and acceptance among potential users. The lack of standardization in design and functionality can hinder interoperability and limit the market's scalability. Competition among established players and emerging startups is intensifying, requiring companies to continuously innovate and offer competitive pricing and value propositions. Finally, the need for specialized training and skilled technicians for proper operation and maintenance can represent a constraint on wider implementation, especially in less developed regions. Addressing these challenges effectively is crucial for achieving the full potential of the active exoskeleton market.

Key Region or Country & Segment to Dominate the Market

The active exoskeleton market shows significant regional variations in growth and adoption. North America, particularly the United States, currently holds a dominant position, driven by advanced technological development, substantial healthcare spending, and a strong focus on workplace safety regulations. Europe follows closely, with a high concentration of research and development activities and established healthcare infrastructure. Asia-Pacific is emerging as a rapidly growing market, with countries like Japan and China witnessing significant investments in exoskeleton technology and a growing elderly population.

  • North America: High technological advancement, considerable healthcare spending, strong regulatory frameworks supporting assistive technologies, and a large aging population contribute to the region's dominance.
  • Europe: A significant presence of research and development, established healthcare infrastructure, and government initiatives promoting assistive technologies support market growth.
  • Asia-Pacific: Rapidly growing economies, increasing geriatric population, significant investments in technological development, and government support are driving market expansion.

Dominant Segments:

  • Medical Rehabilitation: This segment continues to be the largest, driven by the increasing need for assistive devices for stroke patients, individuals with spinal cord injuries, and the elderly. The demand for improved mobility and rehabilitation solutions will fuel growth here.
  • Industrial Applications: The rising demand for increased worker safety and efficiency in demanding industrial settings, particularly logistics and manufacturing, is rapidly expanding this sector. Exoskeletons help reduce strain injuries and improve productivity.

The paragraph above explains the regional and segmental dominance, with North America and the medical rehabilitation segment leading. This is underpinned by the factors listed in bullet points, showing a detailed explanation of the regional disparities and segmental strengths.

Growth Catalysts in Active Exoskeleton Industry

Several factors are catalyzing the growth of the active exoskeleton industry. Technological advancements, such as lighter, more powerful, and energy-efficient designs, are improving the usability and performance of these devices. Increasing government regulations prioritizing worker safety and accessibility for the disabled create a supportive market environment. The rising prevalence of aging populations and related mobility challenges necessitates advanced assistive solutions, driving demand. Finally, growing awareness among industrial sectors regarding productivity and safety benefits is leading to widespread adoption in manufacturing and logistics. These factors collectively fuel market expansion.

Leading Players in the Active Exoskeleton Market

  • Hangzhou Taixi Intelligent Technology
  • Cyberdyne
  • Hocoma
  • ReWalk Robotics
  • Ekso Bionics
  • LockHeed Martin
  • Parker Hannifin
  • Interactive Motion Technologies
  • Panasonic
  • Myomo
  • B-TEMIA Inc.
  • Alter G
  • US Bionics
  • Shipengexo
  • Mebotx
  • Niudi Tech
  • Buffalo-Robot
  • Fourier
  • Milebot
  • Hangzhou Chengtian Technology

Significant Developments in Active Exoskeleton Sector

  • 2020: Ekso Bionics launched a new generation of exoskeletons for medical rehabilitation.
  • 2021: Cyberdyne expanded its HAL for Medical Use into new markets.
  • 2022: ReWalk Robotics received FDA approval for a new exoskeleton model.
  • 2023: Several companies announced partnerships to integrate AI and machine learning in exoskeleton control systems.
  • 2024: Increased investment in research and development of soft exoskeletons for enhanced comfort and dexterity.

Comprehensive Coverage Active Exoskeleton Report

This report provides a comprehensive overview of the active exoskeleton market, including detailed analysis of market trends, driving factors, challenges, key players, and regional variations. It offers valuable insights into the current market landscape and future growth prospects, providing essential information for businesses and investors operating in or considering entering this dynamic and rapidly expanding sector. The extensive data analysis covers both the historical period (2019-2024) and provides a detailed forecast for the future (2025-2033), offering a robust understanding of market evolution.

Active Exoskeleton Segmentation

  • 1. Type
    • 1.1. Lower Limbs Power Type
    • 1.2. Waist Power Type
    • 1.3. Upper Limbs Power Type
  • 2. Application
    • 2.1. Medical Rehabilitation
    • 2.2. Emergency Rescue
    • 2.3. Outdoor
    • 2.4. Other

Active Exoskeleton Segmentation By Geography

  • 1. North America
    • 1.1. United States
    • 1.2. Canada
    • 1.3. Mexico
  • 2. South America
    • 2.1. Brazil
    • 2.2. Argentina
    • 2.3. Rest of South America
  • 3. Europe
    • 3.1. United Kingdom
    • 3.2. Germany
    • 3.3. France
    • 3.4. Italy
    • 3.5. Spain
    • 3.6. Russia
    • 3.7. Benelux
    • 3.8. Nordics
    • 3.9. Rest of Europe
  • 4. Middle East & Africa
    • 4.1. Turkey
    • 4.2. Israel
    • 4.3. GCC
    • 4.4. North Africa
    • 4.5. South Africa
    • 4.6. Rest of Middle East & Africa
  • 5. Asia Pacific
    • 5.1. China
    • 5.2. India
    • 5.3. Japan
    • 5.4. South Korea
    • 5.5. ASEAN
    • 5.6. Oceania
    • 5.7. Rest of Asia Pacific
Active Exoskeleton Market Share by Region - Global Geographic Distribution

Active Exoskeleton Regional Market Share

Loading chart...
Main Logo

Geographic Coverage of Active Exoskeleton

Higher Coverage
Lower Coverage
No Coverage

Active Exoskeleton REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 21.4% from 2020-2034
Segmentation
    • By Type
      • Lower Limbs Power Type
      • Waist Power Type
      • Upper Limbs Power Type
    • By Application
      • Medical Rehabilitation
      • Emergency Rescue
      • Outdoor
      • Other
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Benelux
      • Nordics
      • Rest of Europe
    • Middle East & Africa
      • Turkey
      • Israel
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • ASEAN
      • Oceania
      • Rest of Asia Pacific

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
      • 3.3. Market Restrains
      • 3.4. Market Trends
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Active Exoskeleton Analysis, Insights and Forecast, 2020-2032
    • 5.1. Market Analysis, Insights and Forecast - by Type
      • 5.1.1. Lower Limbs Power Type
      • 5.1.2. Waist Power Type
      • 5.1.3. Upper Limbs Power Type
    • 5.2. Market Analysis, Insights and Forecast - by Application
      • 5.2.1. Medical Rehabilitation
      • 5.2.2. Emergency Rescue
      • 5.2.3. Outdoor
      • 5.2.4. Other
    • 5.3. Market Analysis, Insights and Forecast - by Region
      • 5.3.1. North America
      • 5.3.2. South America
      • 5.3.3. Europe
      • 5.3.4. Middle East & Africa
      • 5.3.5. Asia Pacific
  6. 6. North America Active Exoskeleton Analysis, Insights and Forecast, 2020-2032
    • 6.1. Market Analysis, Insights and Forecast - by Type
      • 6.1.1. Lower Limbs Power Type
      • 6.1.2. Waist Power Type
      • 6.1.3. Upper Limbs Power Type
    • 6.2. Market Analysis, Insights and Forecast - by Application
      • 6.2.1. Medical Rehabilitation
      • 6.2.2. Emergency Rescue
      • 6.2.3. Outdoor
      • 6.2.4. Other
  7. 7. South America Active Exoskeleton Analysis, Insights and Forecast, 2020-2032
    • 7.1. Market Analysis, Insights and Forecast - by Type
      • 7.1.1. Lower Limbs Power Type
      • 7.1.2. Waist Power Type
      • 7.1.3. Upper Limbs Power Type
    • 7.2. Market Analysis, Insights and Forecast - by Application
      • 7.2.1. Medical Rehabilitation
      • 7.2.2. Emergency Rescue
      • 7.2.3. Outdoor
      • 7.2.4. Other
  8. 8. Europe Active Exoskeleton Analysis, Insights and Forecast, 2020-2032
    • 8.1. Market Analysis, Insights and Forecast - by Type
      • 8.1.1. Lower Limbs Power Type
      • 8.1.2. Waist Power Type
      • 8.1.3. Upper Limbs Power Type
    • 8.2. Market Analysis, Insights and Forecast - by Application
      • 8.2.1. Medical Rehabilitation
      • 8.2.2. Emergency Rescue
      • 8.2.3. Outdoor
      • 8.2.4. Other
  9. 9. Middle East & Africa Active Exoskeleton Analysis, Insights and Forecast, 2020-2032
    • 9.1. Market Analysis, Insights and Forecast - by Type
      • 9.1.1. Lower Limbs Power Type
      • 9.1.2. Waist Power Type
      • 9.1.3. Upper Limbs Power Type
    • 9.2. Market Analysis, Insights and Forecast - by Application
      • 9.2.1. Medical Rehabilitation
      • 9.2.2. Emergency Rescue
      • 9.2.3. Outdoor
      • 9.2.4. Other
  10. 10. Asia Pacific Active Exoskeleton Analysis, Insights and Forecast, 2020-2032
    • 10.1. Market Analysis, Insights and Forecast - by Type
      • 10.1.1. Lower Limbs Power Type
      • 10.1.2. Waist Power Type
      • 10.1.3. Upper Limbs Power Type
    • 10.2. Market Analysis, Insights and Forecast - by Application
      • 10.2.1. Medical Rehabilitation
      • 10.2.2. Emergency Rescue
      • 10.2.3. Outdoor
      • 10.2.4. Other
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2025
      • 11.2. Company Profiles
        • 11.2.1 Hangzhou Taixi Intelligent Technology
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Cyberdyne
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 Hocoma
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 ReWalk Robotics
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Ekso Bionics
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 LockHeed Martin
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Parker Hannifin
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 Interactive Motion Technologies
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Panasonic
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 Myomo
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
        • 11.2.11 B-TEMIA Inc.
          • 11.2.11.1. Overview
          • 11.2.11.2. Products
          • 11.2.11.3. SWOT Analysis
          • 11.2.11.4. Recent Developments
          • 11.2.11.5. Financials (Based on Availability)
        • 11.2.12 Alter G
          • 11.2.12.1. Overview
          • 11.2.12.2. Products
          • 11.2.12.3. SWOT Analysis
          • 11.2.12.4. Recent Developments
          • 11.2.12.5. Financials (Based on Availability)
        • 11.2.13 US Bionics
          • 11.2.13.1. Overview
          • 11.2.13.2. Products
          • 11.2.13.3. SWOT Analysis
          • 11.2.13.4. Recent Developments
          • 11.2.13.5. Financials (Based on Availability)
        • 11.2.14 Shipengexo
          • 11.2.14.1. Overview
          • 11.2.14.2. Products
          • 11.2.14.3. SWOT Analysis
          • 11.2.14.4. Recent Developments
          • 11.2.14.5. Financials (Based on Availability)
        • 11.2.15 Mebotx
          • 11.2.15.1. Overview
          • 11.2.15.2. Products
          • 11.2.15.3. SWOT Analysis
          • 11.2.15.4. Recent Developments
          • 11.2.15.5. Financials (Based on Availability)
        • 11.2.16 Niudi Tech
          • 11.2.16.1. Overview
          • 11.2.16.2. Products
          • 11.2.16.3. SWOT Analysis
          • 11.2.16.4. Recent Developments
          • 11.2.16.5. Financials (Based on Availability)
        • 11.2.17 Buffalo-Robot
          • 11.2.17.1. Overview
          • 11.2.17.2. Products
          • 11.2.17.3. SWOT Analysis
          • 11.2.17.4. Recent Developments
          • 11.2.17.5. Financials (Based on Availability)
        • 11.2.18 Fourier
          • 11.2.18.1. Overview
          • 11.2.18.2. Products
          • 11.2.18.3. SWOT Analysis
          • 11.2.18.4. Recent Developments
          • 11.2.18.5. Financials (Based on Availability)
        • 11.2.19 Milebot
          • 11.2.19.1. Overview
          • 11.2.19.2. Products
          • 11.2.19.3. SWOT Analysis
          • 11.2.19.4. Recent Developments
          • 11.2.19.5. Financials (Based on Availability)
        • 11.2.20 Hangzhou Chengtian Technology
          • 11.2.20.1. Overview
          • 11.2.20.2. Products
          • 11.2.20.3. SWOT Analysis
          • 11.2.20.4. Recent Developments
          • 11.2.20.5. Financials (Based on Availability)

List of Figures

  1. Figure 1: Global Active Exoskeleton Revenue Breakdown (million, %) by Region 2025 & 2033
  2. Figure 2: Global Active Exoskeleton Volume Breakdown (K, %) by Region 2025 & 2033
  3. Figure 3: North America Active Exoskeleton Revenue (million), by Type 2025 & 2033
  4. Figure 4: North America Active Exoskeleton Volume (K), by Type 2025 & 2033
  5. Figure 5: North America Active Exoskeleton Revenue Share (%), by Type 2025 & 2033
  6. Figure 6: North America Active Exoskeleton Volume Share (%), by Type 2025 & 2033
  7. Figure 7: North America Active Exoskeleton Revenue (million), by Application 2025 & 2033
  8. Figure 8: North America Active Exoskeleton Volume (K), by Application 2025 & 2033
  9. Figure 9: North America Active Exoskeleton Revenue Share (%), by Application 2025 & 2033
  10. Figure 10: North America Active Exoskeleton Volume Share (%), by Application 2025 & 2033
  11. Figure 11: North America Active Exoskeleton Revenue (million), by Country 2025 & 2033
  12. Figure 12: North America Active Exoskeleton Volume (K), by Country 2025 & 2033
  13. Figure 13: North America Active Exoskeleton Revenue Share (%), by Country 2025 & 2033
  14. Figure 14: North America Active Exoskeleton Volume Share (%), by Country 2025 & 2033
  15. Figure 15: South America Active Exoskeleton Revenue (million), by Type 2025 & 2033
  16. Figure 16: South America Active Exoskeleton Volume (K), by Type 2025 & 2033
  17. Figure 17: South America Active Exoskeleton Revenue Share (%), by Type 2025 & 2033
  18. Figure 18: South America Active Exoskeleton Volume Share (%), by Type 2025 & 2033
  19. Figure 19: South America Active Exoskeleton Revenue (million), by Application 2025 & 2033
  20. Figure 20: South America Active Exoskeleton Volume (K), by Application 2025 & 2033
  21. Figure 21: South America Active Exoskeleton Revenue Share (%), by Application 2025 & 2033
  22. Figure 22: South America Active Exoskeleton Volume Share (%), by Application 2025 & 2033
  23. Figure 23: South America Active Exoskeleton Revenue (million), by Country 2025 & 2033
  24. Figure 24: South America Active Exoskeleton Volume (K), by Country 2025 & 2033
  25. Figure 25: South America Active Exoskeleton Revenue Share (%), by Country 2025 & 2033
  26. Figure 26: South America Active Exoskeleton Volume Share (%), by Country 2025 & 2033
  27. Figure 27: Europe Active Exoskeleton Revenue (million), by Type 2025 & 2033
  28. Figure 28: Europe Active Exoskeleton Volume (K), by Type 2025 & 2033
  29. Figure 29: Europe Active Exoskeleton Revenue Share (%), by Type 2025 & 2033
  30. Figure 30: Europe Active Exoskeleton Volume Share (%), by Type 2025 & 2033
  31. Figure 31: Europe Active Exoskeleton Revenue (million), by Application 2025 & 2033
  32. Figure 32: Europe Active Exoskeleton Volume (K), by Application 2025 & 2033
  33. Figure 33: Europe Active Exoskeleton Revenue Share (%), by Application 2025 & 2033
  34. Figure 34: Europe Active Exoskeleton Volume Share (%), by Application 2025 & 2033
  35. Figure 35: Europe Active Exoskeleton Revenue (million), by Country 2025 & 2033
  36. Figure 36: Europe Active Exoskeleton Volume (K), by Country 2025 & 2033
  37. Figure 37: Europe Active Exoskeleton Revenue Share (%), by Country 2025 & 2033
  38. Figure 38: Europe Active Exoskeleton Volume Share (%), by Country 2025 & 2033
  39. Figure 39: Middle East & Africa Active Exoskeleton Revenue (million), by Type 2025 & 2033
  40. Figure 40: Middle East & Africa Active Exoskeleton Volume (K), by Type 2025 & 2033
  41. Figure 41: Middle East & Africa Active Exoskeleton Revenue Share (%), by Type 2025 & 2033
  42. Figure 42: Middle East & Africa Active Exoskeleton Volume Share (%), by Type 2025 & 2033
  43. Figure 43: Middle East & Africa Active Exoskeleton Revenue (million), by Application 2025 & 2033
  44. Figure 44: Middle East & Africa Active Exoskeleton Volume (K), by Application 2025 & 2033
  45. Figure 45: Middle East & Africa Active Exoskeleton Revenue Share (%), by Application 2025 & 2033
  46. Figure 46: Middle East & Africa Active Exoskeleton Volume Share (%), by Application 2025 & 2033
  47. Figure 47: Middle East & Africa Active Exoskeleton Revenue (million), by Country 2025 & 2033
  48. Figure 48: Middle East & Africa Active Exoskeleton Volume (K), by Country 2025 & 2033
  49. Figure 49: Middle East & Africa Active Exoskeleton Revenue Share (%), by Country 2025 & 2033
  50. Figure 50: Middle East & Africa Active Exoskeleton Volume Share (%), by Country 2025 & 2033
  51. Figure 51: Asia Pacific Active Exoskeleton Revenue (million), by Type 2025 & 2033
  52. Figure 52: Asia Pacific Active Exoskeleton Volume (K), by Type 2025 & 2033
  53. Figure 53: Asia Pacific Active Exoskeleton Revenue Share (%), by Type 2025 & 2033
  54. Figure 54: Asia Pacific Active Exoskeleton Volume Share (%), by Type 2025 & 2033
  55. Figure 55: Asia Pacific Active Exoskeleton Revenue (million), by Application 2025 & 2033
  56. Figure 56: Asia Pacific Active Exoskeleton Volume (K), by Application 2025 & 2033
  57. Figure 57: Asia Pacific Active Exoskeleton Revenue Share (%), by Application 2025 & 2033
  58. Figure 58: Asia Pacific Active Exoskeleton Volume Share (%), by Application 2025 & 2033
  59. Figure 59: Asia Pacific Active Exoskeleton Revenue (million), by Country 2025 & 2033
  60. Figure 60: Asia Pacific Active Exoskeleton Volume (K), by Country 2025 & 2033
  61. Figure 61: Asia Pacific Active Exoskeleton Revenue Share (%), by Country 2025 & 2033
  62. Figure 62: Asia Pacific Active Exoskeleton Volume Share (%), by Country 2025 & 2033

List of Tables

  1. Table 1: Global Active Exoskeleton Revenue million Forecast, by Type 2020 & 2033
  2. Table 2: Global Active Exoskeleton Volume K Forecast, by Type 2020 & 2033
  3. Table 3: Global Active Exoskeleton Revenue million Forecast, by Application 2020 & 2033
  4. Table 4: Global Active Exoskeleton Volume K Forecast, by Application 2020 & 2033
  5. Table 5: Global Active Exoskeleton Revenue million Forecast, by Region 2020 & 2033
  6. Table 6: Global Active Exoskeleton Volume K Forecast, by Region 2020 & 2033
  7. Table 7: Global Active Exoskeleton Revenue million Forecast, by Type 2020 & 2033
  8. Table 8: Global Active Exoskeleton Volume K Forecast, by Type 2020 & 2033
  9. Table 9: Global Active Exoskeleton Revenue million Forecast, by Application 2020 & 2033
  10. Table 10: Global Active Exoskeleton Volume K Forecast, by Application 2020 & 2033
  11. Table 11: Global Active Exoskeleton Revenue million Forecast, by Country 2020 & 2033
  12. Table 12: Global Active Exoskeleton Volume K Forecast, by Country 2020 & 2033
  13. Table 13: United States Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  14. Table 14: United States Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  15. Table 15: Canada Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  16. Table 16: Canada Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  17. Table 17: Mexico Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  18. Table 18: Mexico Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  19. Table 19: Global Active Exoskeleton Revenue million Forecast, by Type 2020 & 2033
  20. Table 20: Global Active Exoskeleton Volume K Forecast, by Type 2020 & 2033
  21. Table 21: Global Active Exoskeleton Revenue million Forecast, by Application 2020 & 2033
  22. Table 22: Global Active Exoskeleton Volume K Forecast, by Application 2020 & 2033
  23. Table 23: Global Active Exoskeleton Revenue million Forecast, by Country 2020 & 2033
  24. Table 24: Global Active Exoskeleton Volume K Forecast, by Country 2020 & 2033
  25. Table 25: Brazil Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  26. Table 26: Brazil Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  27. Table 27: Argentina Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  28. Table 28: Argentina Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  29. Table 29: Rest of South America Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  30. Table 30: Rest of South America Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  31. Table 31: Global Active Exoskeleton Revenue million Forecast, by Type 2020 & 2033
  32. Table 32: Global Active Exoskeleton Volume K Forecast, by Type 2020 & 2033
  33. Table 33: Global Active Exoskeleton Revenue million Forecast, by Application 2020 & 2033
  34. Table 34: Global Active Exoskeleton Volume K Forecast, by Application 2020 & 2033
  35. Table 35: Global Active Exoskeleton Revenue million Forecast, by Country 2020 & 2033
  36. Table 36: Global Active Exoskeleton Volume K Forecast, by Country 2020 & 2033
  37. Table 37: United Kingdom Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  38. Table 38: United Kingdom Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  39. Table 39: Germany Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  40. Table 40: Germany Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  41. Table 41: France Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  42. Table 42: France Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  43. Table 43: Italy Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  44. Table 44: Italy Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  45. Table 45: Spain Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  46. Table 46: Spain Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  47. Table 47: Russia Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  48. Table 48: Russia Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  49. Table 49: Benelux Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  50. Table 50: Benelux Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  51. Table 51: Nordics Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  52. Table 52: Nordics Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  53. Table 53: Rest of Europe Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  54. Table 54: Rest of Europe Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  55. Table 55: Global Active Exoskeleton Revenue million Forecast, by Type 2020 & 2033
  56. Table 56: Global Active Exoskeleton Volume K Forecast, by Type 2020 & 2033
  57. Table 57: Global Active Exoskeleton Revenue million Forecast, by Application 2020 & 2033
  58. Table 58: Global Active Exoskeleton Volume K Forecast, by Application 2020 & 2033
  59. Table 59: Global Active Exoskeleton Revenue million Forecast, by Country 2020 & 2033
  60. Table 60: Global Active Exoskeleton Volume K Forecast, by Country 2020 & 2033
  61. Table 61: Turkey Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  62. Table 62: Turkey Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  63. Table 63: Israel Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  64. Table 64: Israel Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  65. Table 65: GCC Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  66. Table 66: GCC Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  67. Table 67: North Africa Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  68. Table 68: North Africa Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  69. Table 69: South Africa Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  70. Table 70: South Africa Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  71. Table 71: Rest of Middle East & Africa Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  72. Table 72: Rest of Middle East & Africa Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  73. Table 73: Global Active Exoskeleton Revenue million Forecast, by Type 2020 & 2033
  74. Table 74: Global Active Exoskeleton Volume K Forecast, by Type 2020 & 2033
  75. Table 75: Global Active Exoskeleton Revenue million Forecast, by Application 2020 & 2033
  76. Table 76: Global Active Exoskeleton Volume K Forecast, by Application 2020 & 2033
  77. Table 77: Global Active Exoskeleton Revenue million Forecast, by Country 2020 & 2033
  78. Table 78: Global Active Exoskeleton Volume K Forecast, by Country 2020 & 2033
  79. Table 79: China Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  80. Table 80: China Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  81. Table 81: India Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  82. Table 82: India Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  83. Table 83: Japan Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  84. Table 84: Japan Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  85. Table 85: South Korea Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  86. Table 86: South Korea Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  87. Table 87: ASEAN Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  88. Table 88: ASEAN Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  89. Table 89: Oceania Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  90. Table 90: Oceania Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033
  91. Table 91: Rest of Asia Pacific Active Exoskeleton Revenue (million) Forecast, by Application 2020 & 2033
  92. Table 92: Rest of Asia Pacific Active Exoskeleton Volume (K) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step Chart
Bar Chart
Method Chart

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Approach Chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
Analyst Chart

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Active Exoskeleton?

The projected CAGR is approximately 21.4%.

2. Which companies are prominent players in the Active Exoskeleton?

Key companies in the market include Hangzhou Taixi Intelligent Technology, Cyberdyne, Hocoma, ReWalk Robotics, Ekso Bionics, LockHeed Martin, Parker Hannifin, Interactive Motion Technologies, Panasonic, Myomo, B-TEMIA Inc., Alter G, US Bionics, Shipengexo, Mebotx, Niudi Tech, Buffalo-Robot, Fourier, Milebot, Hangzhou Chengtian Technology.

3. What are the main segments of the Active Exoskeleton?

The market segments include Type, Application.

4. Can you provide details about the market size?

The market size is estimated to be USD 850 million as of 2022.

5. What are some drivers contributing to market growth?

N/A

6. What are the notable trends driving market growth?

N/A

7. Are there any restraints impacting market growth?

N/A

8. Can you provide examples of recent developments in the market?

N/A

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3480.00, USD 5220.00, and USD 6960.00 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in million and volume, measured in K.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Active Exoskeleton," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Active Exoskeleton report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Active Exoskeleton?

To stay informed about further developments, trends, and reports in the Active Exoskeleton, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.